Institutions | About Us | Help | Gaeilge
rian logo


Mark
Go Back
An investigation into the potential use of Beta-Galactoside binding protein as a novel anti-leukaemic agent
Spellacy, Neil
THESIS 7607 Chronic myelogenous leukaemia (CML) is characterised at the molecular level by a (9;22) translocation which places the abl proto-oncogene under the control of the breakpoint cluster region (bcr) gene promoter generating a fusion protein (p210) with enhanced tyrosine kinase activity. CML cells are inherently resistant to apoptosis induced by conventional chemotherapeutic agents.
Keyword(s): Haematology and Oncology, Ph.D.; Ph.D. Trinity College Dublin
Publication Date:
2005
Type: Doctoral thesis
Peer-Reviewed: Unknown
Language(s): English
Institution: Trinity College Dublin
Citation(s): Neil Spellacy, 'An investigation into the potential use of Beta-Galactoside binding protein as a novel anti-leukaemic agent', [thesis], Trinity College (Dublin, Ireland). School of Medicine. Discipline of Haematology, 2005, pp 249
Publisher(s): Trinity College (Dublin, Ireland). School of Medicine. Discipline of Haematology
Supervisor(s): Lawler, Mark
First Indexed: 2017-07-05 05:36:17 Last Updated: 2017-07-05 05:36:17